Effect of a Protease Inhibitor-Induced Genetic Bottleneck on Human Immunodeficiency Virus Type 1 env Gene Populations

Por Kitrinos, Kathryn M., Nelson, Julie A. E., Resch, Wolfgang, Swanstrom, Ronald
Publicado em 2005

Turnover of env Variable Region 1 and 2 Genotypes in Subjects with Late-Stage Human Immunodeficiency Virus Type 1 Infection

Por Kitrinos, Kathryn M., Hoffman, Noah G., Nelson, Julie A. E., Swanstrom, Ronald
Publicado em 2003

Independent Evolution of Human Immunodeficiency Virus Type 1 env V1/V2 and V4/V5 Hypervariable Regions during Chronic Infection

Por Harrington, Patrick R., Nelson, Julie A. E., Kitrinos, Kathryn M., Swanstrom, Ronald
Publicado em 2007

Virologic Failure in First-Line Human Immunodeficiency Virus Therapy with a CCR5 Entry Inhibitor, Aplaviroc, plus a Fixed-Dose Combination of Lamivudine-Zidovudine: Nucleoside Reve...

Por Demarest, James F., Amrine-Madsen, Heather, Irlbeck, David M., Kitrinos, Kathryn M.
Publicado em 2009

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope

Por Kitrinos, Kathryn M., Amrine-Madsen, Heather, Irlbeck, David M., Word, J. Michael, Demarest, James F.
Publicado em 2009

Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction

Por Xu, Xiaojun, Thai, Hong, Kitrinos, Kathryn M., Xia, Guoliang, Gaggar, Anuj, Paulson, Matthew, Ganova-Raeva, Lilia, Khudyakov, Yury, Lara, James
Publicado no BMC Bioinformatics (2016)

Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1

Por Ritola, Kimberly, Pilcher, Christopher D., Fiscus, Susan A., Hoffman, Noah G., Nelson, Julie A. E., Kitrinos, Kathryn M., Hicks, Charles B., Eron, Joseph J., Swanstrom, Ronald
Publicado em 2004

HIV Type 1 from a Patient with Baseline Resistance to CCR5 Antagonists Uses Drug-Bound Receptor for Entry

Por Tilton, John C., Amrine-Madsen, Heather, Miamidian, John L., Kitrinos, Kathryn M., Pfaff, Jennifer, Demarest, James F., Ray, Neelanjana, Jeffrey, Jerry L., Labranche, Celia C., Doms, Robert W.
Publicado em 2010

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load

Por Gordon, Stuart C, Krastev, Zahary, Horban, Andrzej, Petersen, Jörg, Sperl, Jan, Dinh, Phillip, Martins, Eduardo B, Yee, Leland J, Flaherty, John F, Kitrinos, Kathryn M, Rustgi, Vinod K, Marcellin, Patrick
Publicado em 2013

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Por Buti, Maria, Tsai, Naoky, Petersen, Joerg, Flisiak, Robert, Gurel, Selim, Krastev, Zahary, Aguilar Schall, Raul, Flaherty, John F., Martins, Eduardo B., Charuworn, Prista, Kitrinos, Kathryn M., Mani Subramanian, G., Gane, Edward, Marcellin, Patrick
Publicado no Dig Dis Sci (2014)